$90.51
-0.0200 (-0.0221%)
At Close: Jun 24, 2026
Dexcom Pummeled On A New FDA Clearance For Key Rival Abbott Laboratories
12:18pm, Monday, 06'th Mar 2023
Dexcom stock toppled Monday after the FDA cleared Abbott Laboratories to pair its body-worn glucose monitors with automated insulin pumps. The post Dexcom Pummeled On A New FDA Clearance For Key Rival
2 Top Dividend Kings to Buy for the Long Haul
09:53am, Saturday, 04'th Mar 2023
These aren't just dividend plays, either.
Apple cloud chief Abbott to step down - Bloomberg News
02:47pm, Friday, 03'rd Mar 2023
Apple Inc's head of cloud services Michael Abbott is leaving the company, joining a growing list of senior officials who have departed the iPhone maker recently, Bloomberg News reported on Friday.
Lucira Stock Jumps over 250% on FDA Approval, Beware Chapter 11
06:01am, Wednesday, 01'st Mar 2023
Lucira Health Inc. (NASDAQ: LHDX) shares spiked up 264% to close at $0.52 on a massive 278 million shares traded on the announcement of FDA approval for its combination at-home COVID-19 and a flu test
March Dividend Kings: 5 Buys, 4 To Watch
06:55pm, Tuesday, 28'th Feb 2023
"There is only one-criterion to be included among the Dividend Kings: a publicly-traded company must increase its total fiscal-year dividend-payout for a minimum of 50 consecutive years."--Dogs of the
Why Abbott Laboratories Stock Bumped Higher Today
06:30pm, Tuesday, 28'th Feb 2023
The company's specialized heart care products appear to prove their value in clinical testing.
Should Abbott and DexCom Investors Be Worried About Apple's Latest News?
05:52am, Tuesday, 28'th Feb 2023
The continuous glucose monitoring market could heat up.
Dividend Stocks To Buy Now? 3 For Your Watchlist
10:33am, Monday, 27'th Feb 2023
Dividend stocks to watch this week.
My Best Dividend Aristocrats For March 2023
10:01am, Saturday, 25'th Feb 2023
NOBL started the year off with a gain of 3.23% in January; it is thus far not faring as well in February, but the ETF is still positive year-to-date. I present 3 strategies that can theoretically beat
Why Is Abbott (ABT) Down 7.7% Since Last Earnings Report?
12:48pm, Friday, 24'th Feb 2023
Abbott (ABT) reported earnings 30 days ago. What's next for the stock?
Better Buy: Abbott Laboratories or DexCom Stock?
09:45am, Friday, 24'th Feb 2023
Both stocks should benefit from the growth in diabetes care.
Is Abbott Stock A Better Pick Over This Pharmaceuticals Bellwether?
08:00am, Friday, 24'th Feb 2023
Both stocks are trading at a similar valuation of a little over 4x trailing revenues.
Selecting Dividend Aristocrats Using SCHD Methodology - Falling Behind
07:42pm, Wednesday, 22'nd Feb 2023
I propose leveraging the stock selection criteria from the underlying index of SCHD to build a portfolio with a subset of Dividend Aristocrats. I am tracking two portfolios built using this process an
Why Abbott Laboratories Stock Sank Today
06:07pm, Wednesday, 22'nd Feb 2023
The company's glucose monitoring business might come under some serious pressure.
Here's Why You Should Retain Abbott (ABT) Stock for Now
12:02pm, Monday, 20'th Feb 2023
Investors are optimistic about Abbott (ABT) owing to continued growth in the Diabetes business.
Sign In
Buy ABT